Association between anticholinergic drug prescription changes and rehabilitation outcome in post-acute hip fractured patients

References

• Bostock CV, Soiza RL, Mangoni AA. Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people. Expert Rev Clin Pharmacol. 2010;3:441–452.
   PubMedGoogle Scholar
• Kachru N, Carnahan RM, Johnson ML, et al. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study. Drugs Aging. 2015;32:379–389.
   PubMed Web of Science ®Google Scholar
• Salahudeen MS, Hilmer SN, Nishtala PS. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc. 2015;63:85–90.
   PubMed Web of Science ®Google Scholar
• Myint PK, Fox C, Kwok CS, et al. Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and older men and women of EPIC-Norfolk prospective population study. Age Ageing. 2015;44:219–225.
   PubMed Web of Science ®Google Scholar
• Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15:753–768.
   PubMed Web of Science ®Google Scholar
• Koshoedo S, Soiza RL, Purkayastha R, et al. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation. Am J Geriatr Pharmacother. 2012;10:251–257.
   PubMedGoogle Scholar
• Hershkovitz A, Angel C, Brill S, et al. The association between anticholinergic drug use and rehabilitation outcome in post-acute hip fractured patients: a retrospective cohort study. Drugs Aging. 2018;35:333–341.
   PubMed Web of Science ®Google Scholar
• Mangoni AA, van Munster BC, Woodman RJ, et al. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry. 2013;21:785–793.
   PubMed Web of Science ®Google Scholar
• Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc. 2011;59:148–157.
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227–2246.
   PubMed Web of Science ®Google Scholar
• Hamilton BB, Granger CV, Sherwin FS, et al. A uniform national data system for medical rehabilitation. In: Fuhrer MJ, editor. Rehabilitation outcomes: analysis and measurement. Baltimore: Paul H Brookes Publishing Co; 1987. p. 137–147.
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-Mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
   PubMed Web of Science ®Google Scholar
• Koh GC, Chen CH, Petrella R, et al. Rehabilitation impact indices and their independent predictors: a systematic review. BMJ Open. 2013;3:e003483.
   PubMed Web of Science ®Google Scholar
• Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15:31.
   PubMed Web of Science ®Google Scholar
• Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4:311–320.
   Google Scholar
• ACB score update (online). [cited 2018 Feb 10]. Available from http://www.agingbraincare.org/uploads/products/ACB_scale_-_legal_size.pdf
   Google Scholar
• Munson JC, Bynum JPW, Bell J-E, et al. Patterns of prescription drug use before and after fragility fracture. JAMA Intern Med. 2016;176:1531–1538.
   PubMed Web of Science ®Google Scholar
• Maclagan LC, Maxwell CJ, Gandhi S, et al. Frailty and potentially inappropriate medication use at nursing home transition. J Am Geriatr Soc. 2017;65:2205–2212.
   PubMed Web of Science ®Google Scholar
• Lee MSS, Hanger HC. Audit of anticholinergic medication changes in older hospitalised patients using the Anticholinergic Drug Scale. Intern Med J. 2017;47:689–694.
   PubMed Web of Science ®Google Scholar
• Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 2007;81:235–241.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Bali V, Carnahan RM, et al. Anticholinergic medication use and risk of fracture in elderly adults with depression. J Am Geriatr Soc. 2016; 64:1492–1497.
   PubMed Web of Science ®Google Scholar
• Spence MM, Karim FA, Lee EA, et al. Risk of injury in older adults using gastrointestinal antispasmodic and anticholinergic medications. J Am Geriatr Soc. 2015;63:1197–1202.
   PubMed Web of Science ®Google Scholar
• Zia A, Kamaruzzaman S, Myint PK, et al. Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas. 2016;84:32–37.
   PubMed Web of Science ®Google Scholar
• Berry SD, Samelson EJ, Hannan MT, et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med. 2007;167:1971–1976.
   PubMed Web of Science ®Google Scholar
• Campbell NL, Perkins AJ, Bradt P, et al. Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population. Pharmacotherapy. 2016;36:1123–1131.
   PubMed Web of Science ®Google Scholar
• Salahudeen MS, Duffull SB, Nishtala PS. Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review. Drugs Aging. 2014;31:185–192.
   PubMed Web of Science ®Google Scholar
• Collamati A, Martone AM, Poscia A, et al. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res. 2016;28:25–35.
   PubMed Web of Science ®Google Scholar
• Yeh YC, Liu CL, Peng LN, et al. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study. Geriatr Gerontol Int. 2013;13:694–700.
   PubMed Web of Science ®Google Scholar
• Magin PJ, Morgan S, Tapley A, et al. Anticholinergic medicines in an older primary care population: a cross-sectional analysis of medicines' levels of anticholinergic activity and clinical indications. J Clin Pharm Ther. 2016;41:486–492.
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Le Couteur DG, Abernethy DR, et al. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother. 2010;44:1725–1732.
   PubMed Web of Science ®Google Scholar